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Abstract: This paper proposes an integrated modelling approach for location planning of 
radiotherapy treatment services based on cancer incidence and road network-based 
accessibility. Previous research efforts have established travel distance/time barriers as a key 
factor affecting access to cancer treatment services, as well as epidemiological studies have 
shown that cancer incidence rates vary with population demography. Our study is buil on the 
evidence that the travel distances to treatment centres and demographic profiles of the 
accessible regions greatly influence the uptake of cancer radiotherapy (RT) services. An 
integrated service planning approach that combines spatially-explicit cancer incidence 
projections, and the placement of new RT services based on road network based accessibility 
measures have never been attempted. This research presents a novel approach for the location 
planning of RT services, and demonstrates its viability by modelling cancer incidence rates 
for different age-sex groups in New South Wales, Australia based on observed cancer 
incidence trends; and estimations of the road network-based access to current NSW treatment 
centres. Using three indices (General Efficiency, Service Availability and Equity), we show 
how the best location for a new RT centre may be chosen when there are multiple competing 
locations.   
Keywords: radiotherapy services, cancer, location planning, accessibility 
 
 
1. Introduction 
Cancer control is a health priority. Cancer is estimated to be the leading cause of burden of 
disease in Australia in 2010, accounting for 19% of the total burden, and has a major impact 
on the Australian community, since one in three men and one in four women in Australia will 
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be diagnosed with cancer by the age of 75. By age 85, the risk increases to one in two for 
men and one in three for women (Cancer Council Australia, 2012). The proportion of elderly 
people in the population will steadily increase over the next decades due to increased life 
expectancy (ROTC, 2012a) and the ‘baby boomers’ ageing population is entering the high 
incidence period, thereby increasing the number of cancer cases. 
Beyond demographic influences, other factors like socio-economic status and ethnicity have 
also an effect on cancer incidence (ROTC, 2012a) along with geographical variations in the 
rate of treatment and survival from cancer (Coory et al., 2013; Yu et al., 2014). As the 
number and diversity of cancer cases increase, the pressure on specialised treatment services 
will increase, calling for better planning and allocation of healthcare resources, particularly at 
the regional level. 
Radiotherapy (RT) is an essential cancer therapy whether aimed at cure or palliation. The 
Collaboration for Cancer Outcomes Research and Evaluation (CCORE) literature-based 
findings were used by the Radiation Oncology Reform Implementation Committee (RORIC) 
to estimate that 52.3% of all diagnosed cancer cases in Australia would benefit from 
radiotherapy at some point after diagnosis. The Australian state health department uses this 
estimate for planning their RT services (Delaney et al., 2003; ROTC 2012b; Morgan 1999). 
Radiotherapy is considered to be most cost effective than surgery and chemotherapy, when 
all costs across the life cycle is considered (Ploquin and Dunscombe 2008). According to the 
RANZCR, radiotherapy provides similar benefit with lower costs for cancer patient treatment 
for cures. RT generally costs about 6 per cent of each health dollar spent fighting cancer, but 
it is a vital part of curing about 40 per cent of all cured cancers. As radiation therapy is 
provided as an outpatient treatment service, the overall treatment costs are less than other 
treatments. In terms of effectiveness, an Australian study stated that external-beam radiation 
therapy is at least as effective as modern Australian surgical techniques (Wilcox et al. 2015). 
It states that men with localised prostate cancer (≈30.0% of all new cancers in men) who are 
treated with external-beam radiation therapy have a cure rate of 95.5% for intermediate-risk 
prostate cancer and 91.3% for high-risk prostate cancer. Also, for breast cancer (≈28% of all 
new cancers in women) treatment studies conducted in Canada and Denmark, have shown a 
9%–10% improvement in overall survival at 10 years for patients that received radiotherapy 
compared with patients who did not receive radiotherapy (Vinh-Hung and Verschraegen 
2004, Ragaz et al. 1997). Like these there are other studies which show better outcomes and 
cost-effectiveness for RT treatments for different types of cancer and their stages. 
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However, measured access to RT services has established that utilization rates are well below 
this optimal number (Mackillop et al., 1997; Barton 2000; Einhorn et al. 1996; Athas et al., 
2000) clearly demonstrating the existence of barriers to access existing RT services. 
Currently, only 38% of cancer sufferers receive radiotherapy during their disease journey 
(ROTC 2012a, Barton and Delaney 2011; Denham 1995) indicating that ~14% of cancer 
sufferers, miss the benefit from RT services that may improved cancer control and 
appropriate evidence-based management (ROTC 2012a, Barton and Delaney 2011). Since the 
proximity of RT facilities to home has been identified as a major factor enhancing 
accessibility to and utilization of RT services (Mackillop et al., 1997; Denham, 1995), it is 
likely that remote and rural patients are facing limited accessibility to radiotherapy on the 
basis of inadequate transportation and lengthy travel. A literature review has highlighted 
travel as a perceived barrier to cancer treatment (Payne et al., 2000). Several national and 
international studies supported the relation between travel distance from radiotherapy centres 
and uptake rates (The Allen Consulting Group, 2012; Delaney et al., 2005; Williams 2009; 
Cancer Care Ontario, 2008; Schroen et al. 2005; Craft et al., 2010; Badde et al., 2011; Wigg 
and Morgan, 2001; Morgan et al., 2010). Although the configuration of centralised networks 
may be driven by resource efficiency savings, it has reflecting clinical need in rural and 
remote areas will appear less resource efficient (Asthana et al 2003). 
Various studies have examined the effect of geographical accessibility, based on travel 
times/distances as proxy to travel effort, on uptake of RT based cancer treatment. For 
example, Madelaine et al. (2002) reported lower treatment rates for rural lung cancer patients 
in France. Punglia et al. (2006) found that increasing distance to the nearest radiotherapy 
centre was associated with a decreasing likelihood of receiving post-mastectomy radiation 
therapy. Greenberg et al., (1988) asserted that lung cancer patients living at greater straight 
line distance from a specialist cancer centre, in rural USA, were significantly more likely to 
undergo surgery but were less likely to receive radiotherapy or chemotherapy than closer 
patients. Athas et al. (2000) also found that breast cancer patients living further than 75 miles 
from a radiotherapy services centre were significantly less likely to receive radiotherapy than 
those living closer. It is possible that the detriment of transportation may be even more 
pronounced in patients who are faced with weeks of daily outpatient treatment, as is common 
for radiation therapy. Some recent studies have reported the location assessment for public 
healthcare facilities in US. Batta et al. (2014) has used p-maxian model considering 
dispersion, population, and equity for obtaining the optimal locations of public facilities. 
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Another study by Burkey et al. (2012) has used location-based comparisons based on 
efficiency and equity to compare healthcare services in four US states. Our paper will use 
some of these indices (general efficiency, service availability and distance-based equity) to 
evaluate the potential RT service locations.   
Recently, Gabriel et al. (2012) presented the results from the data linkage study for 
radiotherapy utilisation rates in NSW and Australian Capital Territory (ACT) for years 2004-
06. They concluded that the radiotherapy utilisation rates decreased with increasing distance 
from patient’s residence to the nearest RT facility (p<0.0001). The study quantified RT rates 
ranging from 27% for patient living within 50 km of RT facility to 19% for patients living 
more than 400 km from the nearest RT facility. Recently, various studies (Shukla et al 
(2014); Shukla et al. (2014); Tyagi et al. (2015)) have only focussed on within organisation 
(or hospital) level process improvements but have not considered patient accessibility 
measures for improvements.  
The planning of efficient and accessible RT services for cancer care at regional level requires 
estimates of current and future cancer demand based on the spatial distribution and evolution 
of various socio-demographic groups, spatial accessibility based on transport network and 
probabilities of re-treatment. In this study, we will develop a modelling tool which can be 
systematically used for planning of radiotherapy services.  
After detailing the data and methods used in the modelling effort, we will demonstrate how 
we have applied these modelling methods to plan and evaluate RT services in NSW.   
2. Approach for planning of radiotherapy services 
The proposed approach for modelling and predicting the future cancer incidences and their 
accessibility to existing RT centres in the state is visualised in Figure 1, and involves datasets 
such as Australian Institute of Health and Welfare (AIHW) cancer incidence data, Australian 
Bureau of Statistics (ABS) population projection dataset, 1km Australian population grid 
dataset, road network dataset, and data about the existing radiotherapy (RT) centres.  
2.1 Datasets used in the proposed approach 
A. AIHW cancer incidence dataset 
The AIHW cancer incidence dataset (AIHW, 2014) provides the information about age group 
and sex specific cancer rates for all and specific cancer types in Australia. The major source 
5 
 
of this data comes from the Australian Cancer Database (ACD) which contains records of all 
the primary, malignant cancers (except basal cell and squamous cell carcinomas of the skin) 
diagnosed in Australia since 1982. The data from ACD is generally used to report national 
cancer statistics such as incidence, trends, projections, survival, and prevalence. The ACD 
data is compiled from the data provided by the state and territory cancer registries through 
Australasian Association of Cancer Registries (AACR). The age-specific rates (ASR) for 
cancer in males and females, in past years, are used to model and predict the cancer 
incidences in the state.  
B.  ABS population projection dataset 
The population projection data prepared by the ABS to permit the Australian Government 
Department of Social Services to plan and evaluate aged care. These projections are based on 
the past trends (over a decade) of fertility, mortality, and migration trends, using the cohort-
component method, where the base population is projected into the future year annually by 
estimating the effect of births, deaths and migration within each age-sex group according to 
the specified fertility, mortality and migration assumptions. This datasets contains the age 
group by sex population numbers for each Statistical Local Area. SLA is an Australian 
Standard Geographical Classification (ASGC) defined area that covers a Local Government 
Area (LGA) or part thereof. The median population of SLAs is about 21,000. The population 
projections cover the period from 2012 to 2026, using the 2011 ABS census year as a base. 
More information about this dataset is present elsewhere (DoH 2013).  
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Figure 1: Methodological approach to determine the accessibility of cancer patients to 
radiotherapy centres 
C.  Australian Population Grid dataset from ABS Australian Bureau of Statistics (ABS) has 
released a 1km population grid covering the entire country based on the Census data collected 
in 2011. This dataset represents the finest resolution digital population data available at the 
national scale According to ABS, this dataset has key advantages of (a) greater spatial 
accuracy in both urban and rural areas, and (b) the ability to efficiently integrate with other 
spatial datasets such environmental data. This dataset is used in travel distance modelling to 
calculate the population coverage. 
D. Road network dataset 
The road network dataset was downloaded from the most up-to-date OpenStreetMap (OSM) 
database, using Quantum GIS software (Gray, 2008). OpenStreetMap is a crowd-sourced 
initiative to collect and map roads, trails, and points of interest, with an ultimate aim of 
building a geographic database that contains every single feature on the planet (Bennett, 
2010). OSM data was selected for this study as it is a readily available and open data source 
with sufficient positional accuracy (Haklay, 2010). 
E. Existing radiotherapy (RT) centres  
The data about the existing RT treatment facilities is accessed from Department of Health, 
Australia. DoH (2014) provides publically available information about radiation therapy 
services including accommodation and travel schemes, facility locations and treatment 
options. The facility locations for RT centres were used for estimating the RT treatment 
accessible regions for future cancer incidences.  
2.2 Methods  
A. Age specific rate (ASR) for cancer incidence modelling 
A non-linear polynomial regression model (of degree 3) was used to model the past trend of 
the cancer incidences. The polynomial regression models have been developed for each age-
sex group for male and female. Age specific rates (ASR) from AIHW dataset, for cancer 
incidences for years 1982 to 2009, have been used to estimate the coefficients of the 
regression model. The model used for ASR regression is: 
𝐴𝐴𝑅𝑡 = 𝛽0 + 𝛽1 × 𝑡 + 𝛽2 × 𝑡2 + +𝛽3 × 𝑡3 + 𝜀𝑡     (1) 
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Where, 𝐴𝐴𝑅𝑡 is the age-specific rate for a particular age-sex group observed in year 𝑡. 𝜀𝑡 is 
assumed to be independent and identically distributed normal random variable with mean 
zero and a constant variance.  
The AIHW cancer incidence dataset for years 1982-2009 is used for estimating coefficients 
𝛽0 - 𝛽3. The confidence level is set to be 95% for the two sided hypothesis test. If the ASR 
model for an age-sex model is found significant, then 𝐴𝐴𝑅𝑡 is estimated based on Eq. (1). 
Otherwise, mean of 𝐴𝐴𝑅𝑡 (where, 𝑡 = 2000,2001, … ,2009) for recent 10 years for a particular 
age-sex group is used for prediction. In this modelling, we have made following assumptions: 
i. this modelling assumes that the incidence is homogeneous across different local 
government areas (LGAs) 
ii. ages were grouped in 5 year interval for this modelling and it assumes that each 
age group is homogeneous 
iii. it is assumed that the past trends in cancer incidences will continue in future       
 
 
B. Predicting the cancer cases  
Once the regression models for the cancer incidence is obtained for each age-sex group, it is 
then used together with the ABS population projections dataset to estimate the future cancer 
cases in the study area. The ABS population dataset is aggregated into a contingency table 
having attributes such as age group, sex, geographical area, and number of people at risk. 
This data table is then used together with the predicted ASR for each year (derived from 
section 2.2.A) to produce cancer cases in different age-sex group in different LGAs. The 
result of this analysis provides cancer cases distributed in various LGAs in future. Once the 
number of cancer cases for future years are identified, it can be used to estimate the future 
radiotherapy demand/workload.  
C. Travel distance modelling and the estimation of population coverage 
Following the literature that supports a strong relationship between travel distance and uptake 
rates (as discussed in Section 1) we calculated driving distance polygons for all treatment 
centres using the popular open source software ‘pgRouting’ (pgRouting Contributors, 2013). 
Routing functions provided by pgRouting are implemented as an extension to the open source 
PostgreSQL/PostGIS geospatial database (Douglas and Douglas, 2005). We were mainly 
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interested in the function ‘pgr_drivingDistance’ to calculate driving distance polygons 
(pgRouting Contributors, 2013). This function computes the cost (distance) to reach every 
node in the network from a given starting node based on a Dijkstra shortest path solution. 
Further details of the Dijkstra algorithm and its applications to road networks can be found in 
Zhan and Noon (1998). 
Firstly, the OSM road network of NSW was imported into PostgreSQL/PostGIS as a 
pgRouting-enabled (i.e. routable) network dataset. A custom SQL function that leverages the 
default pgRouting function ‘pgr_drivingDistance’ was written to loop through all treatment 
centres. This custom function takes each treatment centre as the starting node, and computes 
all nodes in the road network that can be reached within a specified threshold distance. The 
concave polygon that encompasses the collection of nodes computed above was then 
generated using a standard function available in PostGIS. This concave polygon is termed the 
‘constant driving distance polygon’ or isochrone. 
Considering the fact that dwellings are not uniformly distributed in space, the digital dataset 
of the population grid was used to estimate the fraction of the population that lives in a 
particular LGA within a given distance ring.  
Let 𝑃𝑖,𝑗
𝑝  be the portion of population of the ith LGA that lives within the jth distance ring, and 
𝑃𝑖𝑡 be the total population of the i
th LGA, then the fraction of population (of ith LGA) in jth 
distance ring (denoted by 𝐹𝑅𝐴𝑖,𝑗) is given by: 
  𝐹𝑅𝐴𝑖,𝑗 =
𝑃𝑖,𝑗
𝑝
𝑃𝑖
𝑡        (2) 
under the condition ∑𝐹𝑅𝐴𝑖,𝑗=1 for each LGA. 
D. Radiotherapy based treatment demand estimation 
The predicted cancer cases and distance-based LGA ratios (𝐹𝑅𝐴𝑖,𝑗) were used together with 
the radiotherapy rates to estimate the future demand for RT services. The RT rates were 
chosen based on the distance bands provided in Gabriel et al. (2012). They calculated the 
actual radiotherapy treatment rates for cancer patients in NSW & ACT (2004-06) from 
patient treatment records to estimate the effects of geographic variations on the RT rates. The 
road distance between patient residence and the nearest RT centre was estimated to compute 
the rates of radiotherapy for patients living <50Km, 50 -99Km, 100-149 Km, 150-199 Km, 
200-249 Km, 250-299 Km, 300-349 Km, 350-399, and 400+ Km. The dataset used for this 
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study was from 2004-2006. Since this dataset is nearly 10 years old, we have added another 
data source, i.e., local health district cancer treatment data containing radiotherapy data for 
years 2006 -2012. This local health district is out of the eight in NSW. Using both of these 
datasets we have estimated the average radiotherapy rates for cancer patients based on their 
driving distances to the nearest RT facilities. The combined average rates for RT are 
presented in Table 1.  
Table 1: Radiotherapy rates based on driving distances 
Distance Average rates 
<50KM 0.339825 
50-100KM 0.30606 
100-150KM 0.268176 
150-200KM 0.24006 
201-250KM 0.2276 
251-300KM 0.214825 
301-350KM 0.216063 
351-400KM 0.18525 
>400KM 0.161785 
 
Delaney et al. (2005) have summarised the overall optimal radiotherapy utilization rate for 
individual cancers such as skin, breast, lung, gastrointestinal, genitourinary and others. 
Evidence for radiotherapy based treatments such as systematic review of relevant randomised 
studies, randomised/controlled trials, and case series, were used in modelling decision trees 
for determining optimal radiotherapy rates. For more information about these rates and 
methodology see Delaney (2007). The optimal RT rates varied from 0% in case of liver 
cancer patients and 92% for patient with central nervous system tumors. The optimal 
radiotherapy utilisation rate was estimated to be 52.3% of all the notifiable cancer in 
Australia. The SSDB (2012) report indicates that an additional 23% of the cancer patients 
receive at least 2 course of RT (retreatment). Some retreatments are for second cancer and 
other for metastatic events. We have used the estimated rate of 52.3% for determining the 
optimal RT demand for the future year.  
2.3 Evaluation of new radiotherapy centres based on efficiency, service availability and 
equity 
We have used the proposed modelling work to estimate the change in patient access with the 
opening of new RT centre. We have employed three measures to quantitatively 
assess/evaluate the locations of new RT centres – general efficiency, service availability and 
10 
 
equity. These measures have been used previously to evaluate locations of healthcare 
facilities (Batta et al. 2014, Burkey et al. 2012).  
A. General efficiency: for general efficiency, we have considered the average distance 
between any potential cancer patient and his closest RT facility. In literature, various 
researchers have used such measures for evaluating facility location problems in 
healthcare. Batta et al. (2014) have used dispersion and population criteria as the 
proxies for measures of general efficiency. They focussed on minimising the cost of 
providing the service. We are using this measure as a proxy for general efficiency for 
RT service provision. 
B. Service availability: The proxy for service availability is defined to be the population 
coverage for RT treatments. Specifically, the coverage can be measured as the 
proportion of the potential cancer patients that is located within a pre-specified 
distance from their closest RT facility. This measure of coverage was first defined by 
Toregas et al. (1971). According to this measure, a cancer patient is considered 
covered if he is living no farther than 50KMs from the closest facility. The union of 
coverage areas for each RT centre is then represents service availability. We are 
considering 50 KM as the coverage driving distance because previous research studies 
(Gabriel et al. 2012) and our analysis of cancer treatment records indicated that 
patients living less than 50 Kms from the closest RT facility were receiving highest 
rates of radiotherapy based treatments. Radiotherapy is considered a necessary 
component of treatment in 52% of all newly diagnosed cancers (Delaney et al. 2005). 
Radiotherapy is considered to be most cost effective than surgery and chemotherapy, 
when all costs across the life cycle is considered (Ploquin and Dunscombe 2008).  
C. Equity: the equity measure helps to quantify aspects related to fairness, justice of the 
service provision, and neediness. Burkey et al. (2012) have used a measure known as 
Gini index, which is based on Lorenz curve in economics. These curves are used as a 
graphical illustration of inequality for any quantitative study where inequality is 
measured. Gini index is a scalar measure based on Lorenz curve to quantify inequality 
(Gini 1921). Gini index is always between 0 (indicating total equality) and 1 
(indicating total inequality). We have used this measure for determining the equality 
for potential cancer patients to access RT based treatment. 
All of these measures are used to evaluate the alternative locations of new RT centres. All the 
methods in this section are coded in R, which is an open source software environment for 
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statistical computing and graphics using open source R libraries such as maptools, ggplot2, 
plyr, ineq, rgeos, rgdal, sp, RColorBrewer for this approach development and data analysis. 
Interested parties can access the software tools developed in this study freely by contacting 
authors. 
  
3. Results and Discussion 
This study estimates a spatially explicit demand and accessibility for radiotherapy services in 
the NSW state of Australia using methods described above. The choice of the NSW was 
justified by the accurate data currently available for NSW and a well-defined geographical 
area that is known to mirror average demographic distributions in Australia. Figure 2 
illustrates population grid (1Km2) distributed in the whole of NSW state and existing 
locations of RT centres in NSW. 
Non-linear regression for each age-sex group were conducted on the past cancer incidence 
data from AIHW. In both males and females, a statistically significant time trend was found 
for the following groups (α<.05): ‘40-44 yrs’, ‘45-49 yrs’, ‘50-54 yrs’, ‘55-59 yrs’, ‘60-64 
yrs’, ‘65-69 yrs’, ‘70-74 yrs’, ‘75-79 yrs’, ‘80-84 yrs’, and ‘85+ yrs’. Figure 3 illustrates the 
results from non-linear regression analysis (all age groups combined) of cancer incidences 
projected in future and its comparison with the past incidence rates. In Figure 3, the overall 
rates for cancer incidence in females are not increasing compared to the incidences in males. 
The dotted lines in Figure 3 represent the results of the model and the solid lines represent the 
actual rates observed. The results of the ASR prediction model for future years were then 
applied to the ABS population projections.    
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Figure 2: Distribution of population grid (1Km2) and radiotherapy centres in the NSW state 
 
Figure 3: Predicted (points) and observed (solid line) incidence rates (per 100,000) for all 
cancers in males and females in Australia 
The NSW population data provided by the ABS was used in this study. Figure 4 illustrates 
the growth in overall population of NSW from 2011 to 2026. It is evident that the population 
will grow significantly in future. However, the growth in population in different age groups 
and sex varies across NSW.  
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Figure 4: Projected population between 2011 and 2026 based on ABS population projections 
Figure 5 illustrates the growth of population in different age-sex group in year 2011 and 
2026. In year 2026, number of individuals in age groups with a higher cancer incidence (i.e., 
above 50 years) will be larger than 2011 for both females and males (see Figure 5). There 
will be more aged people living in year 2026 in NSW, and because of cancer incidence in the 
aged population sub-groups, more cancer cases.     
 
Figure 5: Age structure of NSW population in years 2011 and 2026 
Figures 6a and 6b illustrate the cancer incidences (cancer cases per 100,000 individuals) for 
year 2011 (Figure 6a) and future year 2026 (Figure 6b). The cancer incidences in all the local 
government area (LGA) of NSW (total of 154) are based on the age-sex specific rates 
obtained based on non-linear regression modelling (as discussed in Section 2.2.A) and future 
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population estimates data (see Figure 5). In year 2011, the average cancer incidence at LGA 
level is approximately 612 per 100,000 individuals. However, it increases to 805 (approx.) 
per 100,000 individuals for future year 2026. Based on the spatial distribution of cancer 
incidences in year 2011 and 2026, which suggests more cancer cases in the coastal, mid-
eastern and southern LGAs of NSW, planning of radiotherapy services for these areas are 
important.     
 
(a)  
(b)  
Figure 6: Overall cancer incidences in year 2011 (a) and 2026 (b) in NSW state of Australia 
Figure 7 depicts driving distance polygons or the accessible regions considering all 
radiotherapy centres as trip origins. We have included existing radiotherapy centres in the 
NSW and also the nearby centres from the two bordering states- Victoria and Queensland. 
This was done to account for patient leakage in to those centres from NSW. As described in 
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Section 2.2.C, for each LGA the fraction of population living in each distance band is 
estimated. Table 2 shows these calculated fractions for two LGAs as an example.  
 
Figure 7: Constant driving distance polygons from radiotherapy centres 
 
Table 2. Estimated fractions of population living in constant driving distance bands from 
radiotherapy centres 
LGA Distance band Fraction of population (𝐹𝑅𝐴𝑖,𝑗) 
Hawkesbury < 50 0.88 
Hawkesbury 50 - 99 0.11 
Hawkesbury 100 - 149 0.01 
Wingecarribee < 50 0.15 
Wingecarribee 50 - 99 0.85 
 
The distance-based LGA ratios (𝐹𝑅𝐴𝑖,𝑗)  in the NSW (illustrated in Table 2) were used 
together with the cancer cases for respective LGA (illustrated in Figure 6) to estimate the 
total number of cancer patients residing in each distance band. The cancer cases residing in 
each distance band can be used for planning and locating new radiotherapy centres.   
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Table 3 provides the comparison/validation of the proposed model with the actual cancer 
cases data from Cancer Institute NSW for a local health district (CI-NSW, 2014). The most 
up to date data available for comparison from Cancer Institute NSW is from 2004-2008 and 
therefore it is used in this study for comparison purposes. Average actual cancer counts per 
year shows that the proposed result for year 2011 matches closely. It can be seen that the 
predicted results are on slightly high compared to actual numbers. This is due to the fact that 
the predictions were made for the year 2011-2015, and it is compared against actual cancer 
counts from year 2004-2008. 
Table 3. Comparison between actual cancer incidence dataset and predicted results 
Local Government 
Area 
Actual Cancer Count 
(2004- 2008) 
Average Actual 
Cancer 
Count/year 
Predicted Count 
(2011) 
Predicted Count 
(2011-2015) 
Kiama 627 125 150 815 
Shellharbour 1,475 295 369 1,987 
Shoalhaven 3,481 696 765 3,987 
Wollongong 5,223 1,045 1,224 6,482 
NSW 177,519 33,504 41,229 218,700 
 
The proposed approach was then applied to estimate change in access of cancer patients with 
the opening of new radiotherapy centre in Shoalhaven LGA (see Figure 3). We have run the 
travel distance modelling method for the scenarios before and after opening of new RT 
centre. The change in cancer patient’s access for before and after opening of RT centre is 
presented in Figure 8. It can be seen that there are more than 600 cancer cases residing in the 
50 km road distance from the nearest RT centre when the new RT centre is operational. The 
number of RT cases residing within 50km of nearest RT centre in the Illawarra and 
Shoalhaven local health district before and after is 1120 and 1511. Interestingly, within 6 
months of opening the Shoalhaven RT service is already managing 500 new RT cases per 
month (A.Miller, personal communication). Due to the opening of new centre, there are less 
cancer cases living in distance bands (in km) 50-99, 100-149, 150-199, 200-249, therefore the 
difference between the numbers of cancer cases is negative. For larger distance bands (250-
299, 300-349, 350-399, 400+), the number of cancer cases are constant for before and after 
RT centre placement.     
17 
 
 
Figure 8: Change in cancer cases access before and after opening of new RT centre in 
Shoalhaven  
To further illustrate the applicability of proposed approach, we have compared different 
scenarios of placement of RT units in NSW. For this, we considered two potential locations 
in NSW to place new RT facility – (i) Dubbo; and (ii) Moruya (see Fig. 9). These scenarios 
are then compared in terms of general efficiency; service accessibility and RT service 
equality (see Section 2.3). The results of the comparison are presented in Table 4.  
 
Figure 9: Potential locations for new RT centre used for scenario analysis 
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Table 4 shows that opening a new RT centre at Dubbo or Moruya offers advantages in terms 
of accessibility to cancer patients. Scenario – Dubbo presents better opportunity for general 
efficiency improvement (i.e. 5.19% more than the baseline), service availability improvement 
(0.71% more); and, service equality increases by 1.51% compared to baseline. However, for 
the case where new RT facility has to be opened in Moruya, the general efficiency and 
service availability increases by 3.88% and 0.59%, but the distance based equality for RT 
services decreases by 0.47%. This implies that opening new RT centre in Dubbo offers better 
accessibility measures compared to Moruya. It should be noted that the Gini index 
(inequality) measure presented in Table 4 should be minimised.    
Table 4: Comparison of scenarios based on general efficiency, service accessibility and 
service equality 
 General Efficiency Service availability Gini Index 
(Inequality) 
Scenario - Dubbo 27.88 (5.19% more) 0.865 (0.71% more) 0.408 (1.51% more) 
Scenario - Moruya 28.27 (3.88% more) 0.864 (0.59% more) 0.416 (0.47% less) 
Baseline 29.41 0.859 0.414 
 
Table 5 illustrates the demand for the RT services based on the radiotherapy rates estimated 
in Section 2.2.D. RT demand at the current service level is calculated by applying RT rates 
by road distance (estimated in Table 1) to the number of cancer patients living in each 
distance bands (see Section 2.2.B and 2.2.C). However, the optimal RT demand is estimated 
by using cancer incidence number and optimal RT utilisation rates (52.3%, see Section 
2.2.D).  
Table 5: RT demand from year 2011 to 2026 
Year RT Demand at current 
service level 
Optimal RT Demand 
based on evidence 
2011 13506 17614 
2012 13905 18144 
2013 14319 18680 
2014 14736 19230 
2015 15180 19796 
2016 15629 20370 
2017 16088 20956 
2018 16536 21560 
2019 16968 22149 
2020 17395 22749 
2021 17810 23378 
2022 18255 24015 
2023 18708 24652 
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2024 19156 25285 
2025 19612 25917 
2026 20070 26545 
 
It can be concluded from Table 5 that supply of RT services significantly lags behind the 
evidence-based optimal demand and new RT centres should be established to deal with such 
shortfall. This trend of shortfall will continue in future at the current service levels. The 
proposed approach offers an innovative way to assess/evaluate the alternative locations of 
new RT services based on – general efficiency, service availability, and equality.  
 
4. Conclusion 
The treatment of cancer, which touches a large proportion of the community, represents a 
significant health and economic burden in Australia. Nearly one in two men and one in three 
women have a lifetime risk of being diagnosed with cancer in NSW. Radiotherapy (RT) 
based cancer treatments are often integral to achieving permanent or long-term remission. 
There will be large demand for RT services for cancer patients in NSW in next ten years. 
However, decision on new linear accelerator (LINAC) units take time, resulting in local 
congestion of services or unreasonable travel time for patients, with some individuals opting 
out of RT treatment reducing demand but not the need. Thus, there is pressing need to 
rationally justify the placement of new radiotherapy centres to effectively meet the future RT 
need of future cancer patients. This study makes a unique contribution to the policy debate on 
placement of RT treatment centres through the establishment of an integrated modelling 
approach. This study marks an attempt at informing the government about the best placement 
locations for RT centres to maximise the RT service capacity to meet future cancer patient 
demand.  
The demonstrated generic approach includes cancer incidence predictive modelling to 
estimate the cancer cases residing within different travel distance bands from the RT centres, 
and is easily applied to the NSW circumstance. The methods described in this research study 
can be applied in other jurisdictions with availability of the necessary data.    
We are aware of limitations in our current approach which are being addressed with more 
research. We have assumed that the OSM road network data is complete. As the OSM data 
becomes more complete in time, we only need to reimport that dataset to update the analysis. 
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In estimating future cancer cases, we assume that the residential locations remain the same, 
but including research on dynamic land use modelling is expected to better account for 
residential area growth. The cancer incidence modelling assumes the same incidence across 
different local government areas (LGAs) and that the past trends will continue in future. 
Lastly, the model can be refined to include detailed information about the individual cancer 
incidences, radiotherapy demand, and accessibility profiles rather than using all inclusive 
assessments. In current study, authors are dealing with all types of cancer and their 
aggregated rates; therefore, survival analysis is not conducted for different types of cancer 
cases and their stages. We hope this type of analysis can be conducted in future based on our 
work. 
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